8 July 2026
Linklaters advises on Neopharmed Gentili’s €890m high yield bond offering
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Giacomo Reali Lead | Linklaters | Partner | high yield | Not stated |
| Makenna Cherry | Linklaters | Associate | high yield | Not stated |
| Francesca Sebastiani | Linklaters | Associate | high yield | Not stated |
| Thomas Alves Pereira | Linklaters | Associate | capital markets | Not stated |
| Marco Carrieri | Linklaters | Counsel | banking | Not stated |
| Maria Chiara De Biasio | Linklaters | Senior associate | banking | Not stated |
| Riccardo Sirchia | Linklaters | Associate | banking | Not stated |
| Rosa Maria Moschella | Linklaters | Associate | banking | Not stated |
| Roberto Egori | Linklaters | Partner | Italian tax | Not stated |
| Fabio Balza | Linklaters | Counsel | Italian tax | Not stated |
| Eugenia Severino | Linklaters | Counsel | Italian tax | Not stated |
| Omer Harel | Linklaters | Counsel | US tax | Not stated |
9 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 890m (€890m)
- What the figure measures
- Issue size
- Client
- initial purchasersUnderwriters
- Counterparties
- Neopharmed Gentili (Issuer)